MedPath

Comparison of Feasibility Between Internal and External Pancreatic Drainage in Pancreaticoduodenectomy

Not Applicable
Conditions
Pancreatic Fistula
Interventions
Procedure: Pancreatic stent
Registration Number
NCT01023594
Lead Sponsor
Seoul National University Hospital
Brief Summary

Pancreatic fistula is one of the most serious complication after pancreatoduodenectomy. To reduce pancreatic fistula, many authors recommend pancreatic stent in pancreatojejunostomy. There are two distinct methods of pancreatic stent insertion: internal stent and external stent. There was few studies comparing these methods in preventing pancreatic fistula. Furthermore, its long-term effect was not known enough. The purpose of this study is to determine which is the best method in preventing pancreatic fistula and to investigate its long term clinical outcomes.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
328
Inclusion Criteria
  • patient who have malignant or benign disease which needs pancreatoduodenectomy
  • patient age: ≥20 and ≤85
Exclusion Criteria
  • patient who had chemotherapy or radiotherapy previous to operation.
  • patient who had severe comorbid disease(cardiac, pulmonary, cerebrovascular)
  • patient who had past medical history of chronic pancreatitis.
  • pancreatic stent size <1mm or >5mm

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
External stentPancreatic stentFeeding tube insert at pancreatojejunostomy site as a stent. And stent tube is brought out through jejunal loop below the hepaticojejunostomy site and abdominal wall.
Internal stentPancreatic stentshort(5cm)internal stent insertion at pancreatojejunostomy site
Primary Outcome Measures
NameTimeMethod
evidence of pancreatic fistula confirmed by serum and drain amylasewithin the first 7 days after surgery
Secondary Outcome Measures
NameTimeMethod
pancreatic endocrine and exocrine function by blood test, stool exam (steatorrhea) and computed tomography (CT) volumetrywithin the first 1 year after surgery

Trial Locations

Locations (8)

Center for Liver Cancer, National Cancer Center

🇰🇷

Goyang-si, Gyeonggi-do, Korea, Republic of

Department of Surgery, Seoul National University Bundang Hospital

🇰🇷

Seongnam, Gyeonggi-do, Korea, Republic of

Department of Surgery, Seoul National University Hospital

🇰🇷

Seoul, Korea, Republic of

Department of Surgery, Samsung Medical Center

🇰🇷

Seoul, Korea, Republic of

Department of Surgery, Korea University Guro Hospital

🇰🇷

Seoul, Korea, Republic of

Department of Surgery, Seoul National University Boramae Hospital

🇰🇷

Seoul, Korea, Republic of

Department of Surgery, Chung-ang University College of Medicine

🇰🇷

Seoul, Korea, Republic of

Department of Surgery, Gangnam Severance Hospital

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath